Claritas Pharmaceuticals, Inc. CLAZF
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.59% | 2,463.64% | 833.33% | ||
| Total Receivables | -38.18% | -21.54% | -6.90% | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 1,581.98% | 7,805.67% | 894.12% | ||
|
|
|||||
| Total Current Assets | 1,581.98% | 7,805.67% | 894.12% | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -72.36% | ||
| Goodwill | -- | -- | -72.36% | ||
| Total Other Intangibles | -- | -- | -72.35% | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -98.72% | 60.00% | -54.55% | ||
| Total Assets | 1.28% | -14.78% | -67.77% | ||
|
|
|||||
| Total Accounts Payable | -57.06% | -70.90% | -27.90% | ||
| Total Accrued Expenses | 4.34% | 0.92% | 46.42% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -34.87% | -28.68% | -41.16% | ||
| Total Finance Division Other Current Liabilities | 40.73% | 42.65% | 5.50% | ||
| Total Other Current Liabilities | 40.73% | 42.65% | 5.50% | ||
| Total Current Liabilities | 14.11% | 7.35% | -1.64% | ||
|
|
|||||
| Total Current Liabilities | 14.11% | 7.35% | -1.64% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -99.44% | -79.53% | -82.58% | ||
| Total Liabilities | -10.17% | -21.04% | -44.06% | ||
|
|
|||||
| Common Stock & APIC | 10.13% | 9.96% | 2.18% | ||
| Retained Earnings | -8.68% | -9.85% | -26.58% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 44.86% | 12.32% | -98.40% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 44.86% | 12.32% | -98.40% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 44.86% | 12.32% | -98.40% | ||
|
|
|||||